EP1509240A4 - Identifizierung von actinobacillus actinomycetemcomitans antigenen zur verwendung bei der diagnose, behandlung und überwachung von periodontalen erkrankungen - Google Patents

Identifizierung von actinobacillus actinomycetemcomitans antigenen zur verwendung bei der diagnose, behandlung und überwachung von periodontalen erkrankungen

Info

Publication number
EP1509240A4
EP1509240A4 EP03781327A EP03781327A EP1509240A4 EP 1509240 A4 EP1509240 A4 EP 1509240A4 EP 03781327 A EP03781327 A EP 03781327A EP 03781327 A EP03781327 A EP 03781327A EP 1509240 A4 EP1509240 A4 EP 1509240A4
Authority
EP
European Patent Office
Prior art keywords
antigens
diagnosis
identification
monitoring
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03781327A
Other languages
English (en)
French (fr)
Other versions
EP1509240A2 (de
Inventor
Martin Dr Handfield
Jeffrey Daniel Hillman
Ann Progulske-Fox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Publication of EP1509240A2 publication Critical patent/EP1509240A2/de
Publication of EP1509240A4 publication Critical patent/EP1509240A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP03781327A 2002-11-20 2003-10-15 Identifizierung von actinobacillus actinomycetemcomitans antigenen zur verwendung bei der diagnose, behandlung und überwachung von periodontalen erkrankungen Withdrawn EP1509240A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23723502A 2002-11-20 2002-11-20
US237235 2002-11-20
PCT/US2003/032645 WO2004045499A2 (en) 2002-11-20 2003-10-15 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases

Publications (2)

Publication Number Publication Date
EP1509240A2 EP1509240A2 (de) 2005-03-02
EP1509240A4 true EP1509240A4 (de) 2008-03-05

Family

ID=32324262

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03781327A Withdrawn EP1509240A4 (de) 2002-11-20 2003-10-15 Identifizierung von actinobacillus actinomycetemcomitans antigenen zur verwendung bei der diagnose, behandlung und überwachung von periodontalen erkrankungen

Country Status (3)

Country Link
EP (1) EP1509240A4 (de)
CA (1) CA2504930A1 (de)
WO (1) WO2004045499A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052860B2 (en) * 2001-11-28 2006-05-30 University Of Florida Research Foundation Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
EP1709971A1 (de) * 2005-04-06 2006-10-11 Ganymed Pharmaceuticals AG Peptidantigene zur Verwendung in Prophylaxe, Behandlung und Diagnose von Poxvirusinfektionen
US8875888B2 (en) * 2009-06-29 2014-11-04 Tts Tooltechnic Systems Ag & Co. Kg Stackable container assembly with reciprocal locking of the stacked containers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011081A2 (en) * 1999-08-06 2001-02-15 Ivigene Corporation Microbial polynucleotides expressed during infection of a host
WO2003068146A2 (en) * 2001-11-28 2003-08-21 University Of Florida Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011081A2 (en) * 1999-08-06 2001-02-15 Ivigene Corporation Microbial polynucleotides expressed during infection of a host
WO2003068146A2 (en) * 2001-11-28 2003-08-21 University Of Florida Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HANDFIELD M ET AL: "IVIAT: A NOVEL METHOD TO IDENTIFY MICROBIAL GENES EXPRESSED SPECIFICALLY DURING HUMAN INFECTIONS", TRENDS IN MICROBIOLOGY, ELSEVIER SCIENCE LTD., KIDLINGTON, GB, vol. 8, no. 7, July 2000 (2000-07-01), pages 336 - 339, XP001041708, ISSN: 0966-842X *

Also Published As

Publication number Publication date
CA2504930A1 (en) 2004-06-03
WO2004045499A2 (en) 2004-06-03
WO2004045499A3 (en) 2004-12-23
EP1509240A2 (de) 2005-03-02

Similar Documents

Publication Publication Date Title
ATE216875T1 (de) Nichtinvasive impfung durch die haut
EP1687733A4 (de) System und prozess zur ermöglichung der bereitstellung von gesundheitsversorgung
DE69942180D1 (de) Vorrichtung zur elektromuskulären stimulation im mundbereich
EP1390711A4 (de) Patientenbefolgungs- und überwachungssystem
MXPA03005342A (es) Derivados de carboxamida y su uso en tratamiento de enfermedades tromboembolicas y tumores.
ATE478653T1 (de) Behandlungsmittel für die nasse haut
EP1520043A4 (de) VERFAHREN ZUR IDENTIFIKATION DER IKKa-FUNKTION UND ANDERER GENE ZUR BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN
ATE258035T1 (de) Wegwerfartikel für menschliche fäkalien
EP1582195A4 (de) Bleichmittel, hautpräparat zur äusseren anwendung und kosmetikum
HUP0501189A2 (hu) Ketoprofent tartalmazó italkészítmény és alkalmazása állati csordák esetében lázat, gyulladást és fájdalmat elõidézõ állapotok kezelésére
MXPA03006629A (es) Composicion para el cuidado de la piel.
GB0108671D0 (en) Skin treatment
IL172416A0 (en) Modified human acid sphingomyelinase having increased activity, and methods for making the same
HK1077521A1 (zh) 找出伴放線杆菌抗原，應用於診斷、治療及監控牙周病
EP1509240A4 (de) Identifizierung von actinobacillus actinomycetemcomitans antigenen zur verwendung bei der diagnose, behandlung und überwachung von periodontalen erkrankungen
AU2003251407A8 (en) Topical treatment for skin irritation
PL362566A1 (en) Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
EP1322778A4 (de) Anwendung von cyr61 in der behandlung und diagnose von menschlichen uterusmyomene
AU2002365941A8 (en) Methods of diagnosis, monitoring and treatment of fertility
HUP0303822A2 (hu) Applikátor kedvező hatású szer fogakra való felvitelére, valamint annak alkalmazása
AU2001289930A1 (en) Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
GB0023599D0 (en) Non-invasive method for determining human photodermatoogical skin-types
MXPA02006448A (es) Preparacion externa para tratar dermatitis alergica.
GB0106316D0 (en) Apparatus for use in the treatment of hair
PT1496884E (pt) Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040519

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1071062

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20080131

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 7/00 20060101ALI20080125BHEP

Ipc: C07K 14/285 20060101ALI20080125BHEP

Ipc: C07K 1/00 20060101ALI20080125BHEP

Ipc: A61K 39/00 20060101ALI20080125BHEP

Ipc: A61K 38/00 20060101AFI20050112BHEP

17Q First examination report despatched

Effective date: 20080609

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20091026

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1071062

Country of ref document: HK